$1.59 Billion is the total value of Rubric Capital Management LP's 63 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COLL | COLLEGIUM PHARMACEUTICAL INC | $57,214,000 | -0.3% | 2,420,214 | 0.0% | 3.60% | +7.5% | |
| AIR | AAR CORP | $50,375,000 | -7.0% | 1,300,000 | 0.0% | 3.17% | +0.2% | |
| GPRE | GREEN PLAINS INC | $44,759,000 | +24.2% | 1,331,330 | 0.0% | 2.82% | +33.8% | |
| RDN | RADIAN GROUP INC | $20,879,000 | -4.3% | 938,368 | 0.0% | 1.31% | +3.1% | |
| MTG | MGIC INVT CORP WIS | $20,686,000 | -1.8% | 1,521,006 | 0.0% | 1.30% | +5.8% | |
| ADV | ADVANTAGE SOLUTIONS INC | $18,220,000 | -8.6% | 1,688,562 | 0.0% | 1.15% | -1.5% | |
| HY | HYSTER YALE MATLS HANDLING Icl a | $16,166,000 | -16.2% | 221,514 | 0.0% | 1.02% | -9.8% | |
| KDNY | CHINOOK THERAPEUTICS INC | $4,601,000 | -9.1% | 325,863 | 0.0% | 0.29% | -2.0% | |
| TXMD | THERAPEUTICSMD INC | $3,325,000 | -11.2% | 2,794,302 | 0.0% | 0.21% | -4.6% | |
| VIAO | VIA OPTRONICS AGsponsored ads | $2,826,000 | -13.2% | 251,855 | 0.0% | 0.18% | -6.3% | |
| REPH | RECRO PHARMA INC | $2,487,000 | -17.2% | 1,076,587 | 0.0% | 0.16% | -10.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAGNACHIP SEMICONDUCTOR CORP | 28 | Q3 2023 | 4.7% |
| BGC PARTNERS INC | 20 | Q2 2023 | 4.6% |
| MR COOPER GROUP INC | 20 | Q3 2023 | 5.9% |
| PAR PACIFIC HOLDINGS INC | 18 | Q3 2023 | 3.9% |
| RADIUS HEALTH INC | 16 | Q2 2022 | 4.3% |
| CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 2.6% |
| HERON THERAPEUTICS INC | 15 | Q3 2023 | 9.0% |
| COLLEGIUM PHARMACEUTICAL INC | 15 | Q3 2023 | 3.9% |
| AAR CORP | 14 | Q3 2023 | 3.2% |
| GREEN PLAINS INC | 14 | Q3 2022 | 4.1% |
View Rubric Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
| BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
| EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
| Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
| Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
| Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
| Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
| Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
| ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
| Core Scientific, Inc./txSold out | February 14, 2022 | 0 | 0.0% |
View Rubric Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-05-31 |
| SC 13D/A | 2024-05-31 |
| DFAN14A | 2024-05-16 |
| 13F-HR | 2024-05-10 |
| DFAN14A | 2024-05-08 |
| DFAN14A | 2024-05-03 |
| DFAN14A | 2024-05-01 |
| DFAN14A | 2024-04-30 |
| DFAN14A | 2024-04-29 |
| DEFC14A | 2024-04-17 |
View Rubric Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.